130 related articles for article (PubMed ID: 3835174)
1. Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.
Romics I; Horváth J; Fehér J; Csontai A
Int Urol Nephrol; 1985; 17(4):323-30. PubMed ID: 3835174
[TBL] [Abstract][Full Text] [Related]
2. [Repeated yearly BCG treatment in superficial bladder cancer].
Somogyi L; Török A; Bors G; Drinóczy M; Horváth R
Orv Hetil; 1989 Mar; 130(13):671-3. PubMed ID: 2726237
[TBL] [Abstract][Full Text] [Related]
3. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
Korovin AI; Savvin VT
Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
[TBL] [Abstract][Full Text] [Related]
4. The investigation of cellular and humoral immune reactivity in patients with tumours of the bladder.
Romics I; Fehér J; Horváth J; Kisbenedek L; Balogh F
Int Urol Nephrol; 1982; 14(3):269-73. PubMed ID: 6186627
[TBL] [Abstract][Full Text] [Related]
5. The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer.
Giannopoulos A; Lykourinas M; Kioupkiolis G; Dimopoulos C
Prog Clin Biol Res; 1984; 162B():123-4. PubMed ID: 6504892
[No Abstract] [Full Text] [Related]
6. Preliminary report of the use of levamisole in the treatment of bladder cancer.
Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
[TBL] [Abstract][Full Text] [Related]
7. [Levamisol and cell-mediated immunity in sarcoidosis (author's transl)].
Votova V; Haskovcová H; Strejcek J
Z Erkr Atmungsorgane; 1977 Aug; 149(2):207-11. PubMed ID: 610098
[TBL] [Abstract][Full Text] [Related]
8. [Intravesical bacillus Calmette-Guérin therapy for superficial bladder tumors].
Hirano A; Shinka T; Uekado Y; Komura T; Kyoku I; Ohkawa T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1769-75. PubMed ID: 3444170
[No Abstract] [Full Text] [Related]
9. [Prognosis of superficial urothelial tumors of the bladder. Evaluation possibilities using the erythrocyte adherence test (SRCA test)].
Krüger R; Reuter F; Deilmann W
Pathologe; 1982 Sep; 3(5):266-71. PubMed ID: 7145864
[No Abstract] [Full Text] [Related]
10. Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Smith RB; Dekernion J; Baron B; Skinner DG; Kaufman JJ
J Urol; 1978 Mar; 119(3):347-9. PubMed ID: 347106
[TBL] [Abstract][Full Text] [Related]
11. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
12. [Levamisol in the treatment of recurrent urinary tract infections].
Lubetkin AM; Remedi RF; Granero M; Brarda O
Bol Med Hosp Infant Mex; 1979; 36(6):1109-12. PubMed ID: 385017
[TBL] [Abstract][Full Text] [Related]
13. [Individual reactivity to Imuran, antithymocytic globulin and levamisol].
Korcáková L; Rovenský J; Pekárek J; Holub M; Kocandrle V
Cas Lek Cesk; 1982 Sep; 121(38-39):1180-3. PubMed ID: 6982754
[No Abstract] [Full Text] [Related]
14. [The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].
Shekarsarai H; Zlotta AR; Drowart A; Van Vooren JP; De Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
Acta Urol Belg; 1997 Mar; 65(1):1-4. PubMed ID: 9245197
[TBL] [Abstract][Full Text] [Related]
15. Long term protection in bladder cancer following intralesional immunotherapy.
Reichert DF; Lamm DL
J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
[TBL] [Abstract][Full Text] [Related]
16. Tumors of the bladder: a multifaceted problem.
Melicow MM
J Urol; 1974 Oct; 112(4):467-78. PubMed ID: 4607319
[No Abstract] [Full Text] [Related]
17. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
18. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
Romics I; Dietmar B; Christoph R
Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
[TBL] [Abstract][Full Text] [Related]
19. Bladder papilloma: therapeutic and cost effect of outpatient department management.
Klein FA; Whitmore WF
Urology; 1981 Sep; 18(3):247-9. PubMed ID: 6792764
[TBL] [Abstract][Full Text] [Related]
20. [Immune reactivity of patients with bladder tumors].
Romics I; Fehér J; Horváth J; Kisbenedek L; Balogh F
Orv Hetil; 1981 Jul; 122(30):1847-8. PubMed ID: 7301352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
